News
1d
MedPage Today on MSNRegistry Data Reassure on JAK Inhibitors' Heart RisksSuggestions that rheumatoid arthritis (RA) patients suffer more cardiovascular events when treated with Janus kinase (JAK) inhibitors compared with tumor necrosis factor (TNF) blockers or other ...
No association was observed between serious infection risk and Janus kinase inhibitor use in patients with immune-mediated inflammatory skin disease.
Only half of patients showed clinical improvement attributed to the medication, but only one new complication occurred.
Duskfade is a love letter to classic action-platformer games, and it's out next year.
Portuguese sneaker brand JAK launches in the UK exclusively at Selfridges. Known for ethically sourced, high-quality leather ...
Hosted on MSN29d
Treating chronic inflammatory diseases with JAK inhibitorsJanus kinase (JAK) inhibitors are an important treatment option for people with chronic inflammatory diseases such as rheumatoid arthritis, psoriasis, Crohn's disease or ulcerative colitis.
The off-label use of JAK inhibitors to treat JDM is common in pediatric rheumatology, with barriers to use including limited clinical trial data and insurance approval.
A prospective registry study found a greater risk for infections associated with JAK inhibitors in adolescents and adults with moderate to severe atopic dermatitis compared with biologics.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results